Dewetting: From Physics to the Biology of Intoxicated Cells
Pathogenic micro organism colonize or disseminate into cells and tissues by inducing large-scale remodeling of host membranes. The bodily phenomena underpinning these big membrane extension and deformation are poorly understood. Invasive strategies of pathogens have been simply recently enriched by the define of a spectacular mode of opening of huge transendothelial cell macroaperture (TEM) tunnels correlated to the dissemination of EDIN-producing strains of Staphylococcus aureus by means of a hematogenous route or to the induction of gelatinous edema triggered by the edema toxin from Bacillus anthracis.
Remarkably, these extraordinarily dynamic tunnels shut shortly after they attain a maximal measurement. Opening and closure of TEMs in cells lasts for hours with out inducing endothelial cell demise. Multidisciplinary analysis have started to produce a broader perspective of every the molecular determinants controlling cytoskeleton group at newly curved membranes generated by the opening of TEMs and the bodily processes controlling the dynamics of these tunnels.
Proper right here we speak in regards to the analogy between the opening of TEM tunnels and the bodily concepts of dewetting, stemming from a parallel between membrane stress and ground stress. This analogy provides a broad framework to analysis biophysical constraints in cell membrane dynamics and their diversion by positive invasive microbial brokers
Present advances in myeloid-derived suppressor cell biology
In latest occasions, discovering out the place of myeloid-derived suppressor cells (MDSCs) in numerous pathological inflammatory conditions has become a very energetic evaluation area. Although the place of MDSCs in most cancers is relatively successfully established, their place in non-cancerous pathological conditions stays in its infancy resulting in rather a lot confusion. Our targets on this overview are to cope with some present advances in MDSC evaluation in order to lower such confusion and to produce an notion into their function inside the context of various illnesses.
The following issues is perhaps significantly centered upon:
(1) definition and characterization of MDSCs;
(2) whether or not or not all MDSC populations embrace immature cells;
(3) technical factors in MDSC isolation, estimation and characterization;
(4) the origin of MDSCs and their anatomical distribution in effectively being and sickness;
(5) mediators of MDSC development and accumulation;
(6) parts that determine the expansion of 1 MDSC inhabitants over the other;
(7) the Yin and Yang roles of MDSCs. Moreover, the capabilities of MDSCs is perhaps addressed all by the textual content material.

CBFB Blocking Peptide |
|||
20-abx061064 | Abbexa |
|
|
MAPKAPK3 Blocking Peptide |
|||
20-abx061065 | Abbexa |
|
|
MOB3C Blocking Peptide |
|||
20-abx061067 | Abbexa |
|
|
DPF2 Blocking Peptide |
|||
20-abx061068 | Abbexa |
|
|
TAF15 Blocking Peptide |
|||
20-abx061069 | Abbexa |
|
|
FAM84B Blocking Peptide |
|||
20-abx061070 | Abbexa |
|
|
GTF2IRD1 Blocking Peptide |
|||
20-abx061071 | Abbexa |
|
|
COL19A1 Blocking Peptide |
|||
20-abx061072 | Abbexa |
|
|
CYP2W1 Blocking Peptide |
|||
20-abx061073 | Abbexa |
|
|
RAD21 Blocking Peptide |
|||
20-abx061075 | Abbexa |
|
|
PSMC3 Blocking Peptide |
|||
20-abx061076 | Abbexa |
|
|
PSMD11 Blocking Peptide |
|||
20-abx061077 | Abbexa |
|
|
MRPS9 Blocking Peptide |
|||
20-abx061078 | Abbexa |
|
|
MRPL41 Blocking Peptide |
|||
20-abx061079 | Abbexa |
|
|
MRPL48 Blocking Peptide |
|||
20-abx061080 | Abbexa |
|
|
RPS12 Blocking Peptide |
|||
20-abx061081 | Abbexa |
|
|
RPS13 Blocking Peptide |
|||
20-abx061082 | Abbexa |
|
|
ACSS1 Blocking Peptide |
|||
20-abx061084 | Abbexa |
|
|
AKR1C2 Blocking Peptide |
|||
20-abx061085 | Abbexa |
|
|
ACER3 Blocking Peptide |
|||
20-abx061086 | Abbexa |
|
|
ATP5I Blocking Peptide |
|||
20-abx061087 | Abbexa |
|
|
ATP5C1 Blocking Peptide |
|||
20-abx061088 | Abbexa |
|
|
CNTROB Blocking Peptide |
|||
20-abx061089 | Abbexa |
|
|
CEP78 Blocking Peptide |
|||
20-abx061090 | Abbexa |
|
|
DMGDH Blocking Peptide |
|||
20-abx061093 | Abbexa |
|
|
EIF3D Blocking Peptide |
|||
20-abx061095 | Abbexa |
|
|
FUBP3 Blocking Peptide |
|||
20-abx061096 | Abbexa |
|
|
GHITM Blocking Peptide |
|||
20-abx061097 | Abbexa |
|
|
SAR1B Blocking Peptide |
|||
20-abx061098 | Abbexa |
|
|
NXPH3 Blocking Peptide |
|||
20-abx061101 | Abbexa |
|
|
PP15 Blocking Peptide |
|||
20-abx061102 | Abbexa |
|
|
LONP2 Blocking Peptide |
|||
20-abx061104 | Abbexa |
|
|
PEX10 Blocking Peptide |
|||
20-abx061105 | Abbexa |
|
|
PABPC5 Blocking Peptide |
|||
20-abx061106 | Abbexa |
|
|
PRPF39 Blocking Peptide |
|||
20-abx061107 | Abbexa |
|
|
PPM1K Blocking Peptide |
|||
20-abx061108 | Abbexa |
|
|
RSAD1 Blocking Peptide |
|||
20-abx061109 | Abbexa |
|
|
Renin Blocking Peptide |
|||
20-abx061110 | Abbexa |
|
|
SH2D2A Blocking Peptide |
|||
20-abx061113 | Abbexa |
|
|
SCN4B Blocking Peptide |
|||
20-abx061114 | Abbexa |
|
|
SFRS15 Blocking Peptide |
|||
20-abx061115 | Abbexa |
|
|
TCEAL1 Blocking Peptide |
|||
20-abx061116 | Abbexa |
|
|
TMBIM4 Blocking Peptide |
|||
20-abx061117 | Abbexa |
|
|
WIPF1 Blocking Peptide |
|||
20-abx061118 | Abbexa |
|
|
ZFYVE19 Blocking Peptide |
|||
20-abx061119 | Abbexa |
|
|
ZNT1 Blocking Peptide |
|||
20-abx061120 | Abbexa |
|
|
BNIP3 Blocking Peptide |
|||
20-abx061122 | Abbexa |
|
|
SHIP2 Blocking Peptide |
|||
20-abx061126 | Abbexa |
|
|
CD248 Blocking Peptide |
|||
20-abx061132 | Abbexa |
|
|
CD225 Blocking Peptide |
|||
20-abx061133 | Abbexa |
|
|
CD276 Blocking Peptide |
|||
20-abx061134 | Abbexa |
|
|
CD300d Blocking Peptide |
|||
20-abx061135 | Abbexa |
|
|
GPR10 Blocking Peptide |
|||
20-abx061136 | Abbexa |
|
|
GPCR135 Blocking Peptide |
|||
20-abx061137 | Abbexa |
|
|
STAT5 Blocking Peptide |
|||
20-abx061148 | Abbexa |
|
|
TGFBR2 Blocking Peptide |
|||
20-abx061149 | Abbexa |
|
|
ABL1 Blocking Peptide |
|||
20-abx061151 | Abbexa |
|
|
SPHK2 Blocking Peptide |
|||
20-abx061153 | Abbexa |
|
|
RPS6KC1 Blocking Peptide |
|||
20-abx061156 | Abbexa |
|
|
MMTAG2 Blocking Peptide |
|||
20-abx061157 | Abbexa |
|
|
MRG15 Blocking Peptide |
|||
20-abx061158 | Abbexa |
|
|
CADM1 Blocking Peptide |
|||
20-abx061159 | Abbexa |
|
|
APPBP2 Blocking Peptide |
|||
20-abx061160 | Abbexa |
|
|
CEP135 Blocking Peptide |
|||
20-abx061162 | Abbexa |
|
|
EIF3J Blocking Peptide |
|||
20-abx061163 | Abbexa |
|
|
MRPS22 Blocking Peptide |
|||
20-abx061164 | Abbexa |
|
|
RIMS4 Blocking Peptide |
|||
20-abx061167 | Abbexa |
|
|
RHOBTB3 Blocking Peptide |
|||
20-abx061168 | Abbexa |
|
|
OUTB1 Blocking Peptide |
|||
20-abx061170 | Abbexa |
|
|
NRBP1 Blocking Peptide |
|||
20-abx061171 | Abbexa |
|
|
GPR40 Blocking Peptide |
|||
20-abx061175 | Abbexa |
|
|
COX10 Blocking Peptide |
|||
20-abx061180 | Abbexa |
|
|
RAB34 Blocking Peptide |
|||
20-abx061185 | Abbexa |
|
|
RASD2 Blocking Peptide |
|||
20-abx061189 | Abbexa |
|
|
ALT2 Blocking Peptide |
|||
20-abx061190 | Abbexa |
|
|
DZIP3 Blocking Peptide |
|||
20-abx061191 | Abbexa |
|
|
CaMK4 Blocking Peptide |
|||
20-abx061202 | Abbexa |
|
|
Dematin Blocking Peptide |
|||
20-abx061203 | Abbexa |
|
|
TBX10 Blocking Peptide |
|||
20-abx061209 | Abbexa |
|
|
TAF5L Blocking Peptide |
|||
20-abx061210 | Abbexa |
|
|
PSKH1 Blocking Peptide |
|||
20-abx061211 | Abbexa |
|
|
ZNF24 Blocking Peptide |
|||
20-abx061212 | Abbexa |
|
|
EPHA1 Blocking Peptide |
|||
20-abx061213 | Abbexa |
|
|
GTF2H1 Blocking Peptide |
|||
20-abx061214 | Abbexa |
|
|
Recoverin Blocking Peptide |
|||
20-abx061215 | Abbexa |
|
|
BUD31 Blocking Peptide |
|||
20-abx061216 | Abbexa |
|
|
MKK4 Blocking Peptide |
|||
20-abx061217 | Abbexa |
|
|
ID4 Blocking Peptide |
|||
20-abx061218 | Abbexa |
|
|
FOXK1 Blocking Peptide |
|||
20-abx061221 | Abbexa |
|
|
TRIM25 Blocking Peptide |
|||
20-abx061223 | Abbexa |
|
|
DOK7 Blocking Peptide |
|||
20-abx061226 | Abbexa |
|
|
PIG3 Blocking Peptide |
|||
20-abx061227 | Abbexa |
|
|
ZNF397 Blocking Peptide |
|||
20-abx061229 | Abbexa |
|
|
ZNF596 Blocking Peptide |
|||
20-abx061231 | Abbexa |
|
|
ZNF785 Blocking Peptide |
|||
20-abx061232 | Abbexa |
|
|
ZNF668 Blocking Peptide |
|||
20-abx061233 | Abbexa |
|
|
BTBD6 Blocking Peptide |
|||
20-abx061234 | Abbexa |
|
|
CDK15 Blocking Peptide |
|||
20-abx061235 | Abbexa |
|
|
BEGAIN Blocking Peptide |
|||
20-abx061236 | Abbexa |
|
|
YTHDF1 Blocking Peptide |
|||
20-abx061237 | Abbexa |
|
|
ZNF436 Blocking Peptide |
|||
20-abx061238 | Abbexa |
|
|
PBOV1 Blocking Peptide |
|||
20-abx061239 | Abbexa |
|
|
BCA3 Blocking Peptide |
|||
20-abx061240 | Abbexa |
|
|
SERINC1 Blocking Peptide |
|||
20-abx061241 | Abbexa |
|
|
ZC3H7B Blocking Peptide |
|||
20-abx061243 | Abbexa |
|
|
ARMCX3 Blocking Peptide |
|||
20-abx061244 | Abbexa |
|
|
STAG3 Blocking Peptide |
|||
20-abx061245 | Abbexa |
|
|
TCFL5 Blocking Peptide |
|||
20-abx061246 | Abbexa |
|
|
SUR2 Blocking Peptide |
|||
20-abx061247 | Abbexa |
|
|
CHKB Blocking Peptide |
|||
20-abx061248 | Abbexa |
|
|
ERGIC3 Blocking Peptide |
|||
20-abx061249 | Abbexa |
|
|
DYRK1B Blocking Peptide |
|||
20-abx061251 | Abbexa |
|
|
SUPT16H Blocking Peptide |
|||
20-abx061252 | Abbexa |
|
|
IRAK3 Blocking Peptide |
|||
20-abx061253 | Abbexa |
|
|
CDC6 Blocking Peptide |
|||
20-abx061256 | Abbexa |
|
|
ARRDC2 Blocking Peptide |
|||
20-abx061258 | Abbexa |
|
|
ASF1B Blocking Peptide |
|||
20-abx061259 | Abbexa |
|
|
CABLES2 Blocking Peptide |
|||
20-abx061260 | Abbexa |
|
|
CADM2 Blocking Peptide |
|||
20-abx061261 | Abbexa |
|
|
CADM3 Blocking Peptide |
|||
20-abx061262 | Abbexa |
|
|
CARD11 Blocking Peptide |
|||
20-abx061263 | Abbexa |
|
|
DNAJB4 Blocking Peptide |
|||
20-abx061265 | Abbexa |
|
|
GSPT1 Blocking Peptide |
|||
20-abx061266 | Abbexa |
|
|
MRGPRX2 indicators its significance in cutaneous mast cell biology: Does MRGPRX2 be part of mast cells and atopic dermatitis?
The invention of MRGPRX2 marks a necessary change in MC biology, explaining non-IgE-mediated scientific phenomena relying on MCs. As receptor for quite a few remedy, MRGPRX2 is important to drug-induced hypersensitivity.
Nonetheless, not solely remedy, however moreover endogenous mediators like neuropeptides and host safety peptides activate MRGPRX2, suggesting its broad affect in cutaneous pathophysiology.
Proper right here, we give a brief overview of MRGPRX2 and its regulation by microenvironmental stimuli, which assist MCs and shall be altered in pores and pores and skin points, and briefly contact on the purposeful packages elicited by MRGPRX2 ligation. Analysis in Mrgprb2-deficient mice (the murine ortholog) help illuminate MRGPRX2’s function in effectively being and sickness.
Present advances on this model assist the long-suspected operational unit between MCs and nerves, with MRGPRX2 being an vital component. Based on the restricted proof for a big contribution of FcεRI/IgE-activated MCs to atopic dermatitis (AD), we develop the hypothesis that MRGPRX2 constitutes the missing hyperlink connecting MCs and AD, a minimum of in chosen endotypes.
Help comes from the multifold changes inside the MC-neuronal system of AD pores and pores and skin (e.g. bigger density of MCs and nearer connections between MCs and nerves, elevated PAR-2/Substance P).
We theorize that these deregulations suffice to impress AD, nonetheless exterior triggers, numerous which activating MRGPRX2 themselves (e.g. Staphylococcus aureus) extra feed into the loop. Itch, most likely probably the most burdensome hallmark of AD, is usually non-histaminergic nonetheless tryptase-dependent, and tryptase is preferentially launched upon MRGPRX2 activation. On account of MRGPRX2 is a very energetic evaluation space, a couple of of the current gaps are susceptible to be closed shortly.
Non-Muscle Myosin II in Axonal Cell Biology: From the Growth Cone to the Axon Preliminary Part
By binding to actin filaments, non-muscle myosin II (NMII) generates actomyosin networks that preserve distinctive contractile properties. Their dynamic nature is vital for neuronal biology along with the establishment of polarity, progress cone formation and motility, axon progress all through enchancment (and axon regeneration inside the grownup), radial and longitudinal axonal stress, and synapse formation and efficiency.
On this overview, we speak in regards to the current information on the spatial distribution and efficiency of the actomyosin cytoskeleton in quite a few axonal compartments.
We highlight a couple of of the plain contradictions and open questions inside the space, along with the place of NMII inside the regulation of axon progress and regeneration, the possibility that NMII structural affiliation alongside the axon shaft would possibly administration every radial and longitudinal contractility, and the mechanism and purposeful goal underlying NMII enrichment inside the axon preliminary part.
With the advances in reside cell imaging and super choice microscopy, it is anticipated that inside the near future the spatial distribution of NMII inside the axon, and the mechanisms by which it participates in axonal biology is perhaps extra untangled.
Salicylic acid |
|||
SB0817 | Bio Basic | 250g | EUR 102.2 |
Sorbic acid |
|||
SB0899 | Bio Basic | 500g | EUR 71.75 |
Succinic acid |
|||
SD0496 | Bio Basic | 500g | EUR 70.01 |
Anacardic Acid |
|||
M37000 | EpiGentek | 5 mg | EUR 183.4 |
Description: kits suitable for this type of research |
Valproic Acid |
|||
M41002 | EpiGentek | 500 mg | EUR 128.3 |
Description: The best epigenetics products |
Ginkgolic acid |
|||
M75004 | EpiGentek | 5 mg | EUR 701.05 |
Description: kits suitable for this type of research |
Mucic acid |
|||
MD1225 | Bio Basic | 50g | EUR 69.14 |
Nalidixic Acid |
|||
N011-100G | TOKU-E | 100 g | EUR 172 |
Nalidixic Acid |
|||
N011-25G | TOKU-E | 25 g | EUR 77 |
Neochlorogenic acid |
|||
N050-10MG | TOKU-E | 10 mg | EUR 172 |
Neochlorogenic acid |
|||
N050-50MG | TOKU-E | 50 mg | EUR 617 |
Oxolinic acid |
|||
O002-25G | TOKU-E | 25 g | EUR 335 |
Oxolinic acid |
|||
O002-5G | TOKU-E | 5 g | EUR 120 |
Lactobionic acid |
|||
L017-25G | TOKU-E | 25 g | EUR 99 |
Mycophenolic Acid |
|||
M012-250MG | TOKU-E | 250 mg | EUR 212 |
Mycophenolic Acid |
|||
M012-50MG | TOKU-E | 50 mg | EUR 73 |
Pipemidic acid |
|||
P009-100G | TOKU-E | 100 g | EUR 411 |
Pipemidic acid |
|||
P009-10G | TOKU-E | 10 g | EUR 91 |
Pseudomonic acid |
|||
P095-100MG | TOKU-E | 100 mg | EUR 708 |
Pseudomonic acid |
|||
P095-25MG | TOKU-E | 25 mg | EUR 224 |
Zoledronic Acid |
|||
HY-13777 | MedChemExpress | 100mg | EUR 229 |
Retinoic acid |
|||
HY-14649 | MedChemExpress | 10mM/1mL | EUR 126 |
Levomefolic acid |
|||
HY-14781 | MedChemExpress | 10mM/1mL | EUR 231 |
Minodronic acid |
|||
HY-16322 | MedChemExpress | 10mg | EUR 108 |
Folic acid |
|||
HY-16637 | MedChemExpress | 500mg | EUR 108 |
Pirinixic acid |
|||
HY-16995 | MedChemExpress | 250mg | EUR 354 |
Folinic acid |
|||
HY-17556 | MedChemExpress | 100mg | EUR 667 |
Lipoic acid |
|||
HY-18733 | MedChemExpress | 500mg | EUR 133 |
Ethylmalonic acid |
|||
HY-34740 | MedChemExpress | 500mg | EUR 108 |
Octanoic acid |
|||
HY-41417 | MedChemExpress | 5g | EUR 119 |
(-)-Aspartic acid |
|||
HY-42068 | MedChemExpress | 5g | EUR 119 |
Asparagusic acid |
|||
HY-50730 | MedChemExpress | 100mg | EUR 609 |
Chenodeoxycholic Acid |
|||
HY-76847 | MedChemExpress | 10mM/1mL | EUR 126 |
Glyoxalic acid |
|||
HY-79494 | MedChemExpress | 500mg | EUR 108 |
Benzenebutyric acid |
|||
HY-A0281 | MedChemExpress | 500mg | EUR 108 |
Pamidronic acid |
|||
HY-B0012 | MedChemExpress | 10mM/1mL | EUR 172 |
Risedronic acid |
|||
HY-B0148 | MedChemExpress | 500mg | EUR 402 |
Tranexamic acid |
|||
HY-B0149 | MedChemExpress | 10mM/1mL | EUR 113 |
Salicylic acid |
|||
HY-B0167 | MedChemExpress | 50g | EUR 160 |
Lithocholic acid |
|||
HY-B0172 | MedChemExpress | 500mg | EUR 108 |
Ellagic acid |
|||
HY-B0183 | MedChemExpress | 500mg | EUR 108 |
Etidronic acid |
|||
HY-B0302 | MedChemExpress | 1g | EUR 142 |
Tolfenamic Acid |
|||
HY-B0335 | MedChemExpress | 500mg | EUR 108 |
Nalidixic acid |
|||
HY-B0398 | MedChemExpress | 500mg | EUR 108 |
Mycophenolic acid |
|||
HY-B0421 | MedChemExpress | 1g | EUR 185 |
Niflumic acid |
|||
HY-B0493 | MedChemExpress | 10mM/1mL | EUR 141 |
Ibandronic acid |
|||
HY-B0515A | MedChemExpress | 100mg | EUR 215 |
Cyclamic acid |
|||
HY-B0541 | MedChemExpress | 5g | EUR 533 |
Mefenamic acid |
|||
HY-B0574 | MedChemExpress | 500mg | EUR 113 |
Hyaluronic acid |
|||
HY-B0633A | MedChemExpress | 50mg | EUR 119 |
Eicosapentaenoic Acid |
|||
HY-B0660 | MedChemExpress | 10mM/1mL | EUR 134 |
Azelaic acid |
|||
HY-B0704 | MedChemExpress | 10mM/1mL | EUR 113 |
Carglumic Acid |
|||
HY-B0711 | MedChemExpress | 200mg | EUR 119 |
Fenofibric acid |
|||
HY-B0760 | MedChemExpress | 500mg | EUR 108 |
Betulinic acid |
|||
HY-10529 | MedChemExpress | 10mM/1mL | EUR 131 |
Valproic acid |
|||
HY-10585 | MedChemExpress | 10mM/1mL | EUR 113 |
Gadopentetic acid |
|||
HY-107353 | MedChemExpress | 100mg | EUR 108 |
Arundic Acid |
|||
HY-107661 | MedChemExpress | 5mg | EUR 337 |
Medronic acid |
|||
HY-108309 | MedChemExpress | 10mM/1mL | EUR 113 |
Arachidonic acid |
|||
HY-109590 | MedChemExpress | 10mg | EUR 131 |
Aminomalonic acid |
|||
HY-112052 | MedChemExpress | 100mg | EUR 223 |
Urocanic acid |
|||
HY-113008 | MedChemExpress | 500mg | EUR 108 |
Hydroxypyruvic acid |
|||
HY-113013 | MedChemExpress | 5mg | EUR 371 |
Elaidic acid |
|||
HY-113016 | MedChemExpress | 100mg | EUR 108 |
Mevalonic acid |
|||
HY-113071 | MedChemExpress | 5mg | EUR 268 |
Argininic acid |
|||
HY-113079 | MedChemExpress | 5mg | EUR 223 |
Paullinic acid |
|||
HY-113094 | MedChemExpress | 10mg | EUR 302 |
Indolelactic acid |
|||
HY-113099 | MedChemExpress | 10mg | EUR 131 |
Eicosadienoic acid |
|||
HY-113130 | MedChemExpress | 25mg | EUR 119 |
Bovinic acid |
|||
HY-113162 | MedChemExpress | 10mg | EUR 153 |
Ursocholic acid |
|||
HY-113212 | MedChemExpress | 10mg | EUR 452 |
Hydroxyphenyllactic acid |
|||
HY-113219 | MedChemExpress | 50mg | EUR 176 |
Oxoadipic acid |
|||
HY-113227 | MedChemExpress | 10mg | EUR 268 |
Dihydrofolic acid |
|||
HY-113267 | MedChemExpress | 5mg | EUR 337 |
Homogentisic acid |
|||
HY-113283 | MedChemExpress | 10mg | EUR 142 |
Ureidopropionic acid |
|||
HY-113285 | MedChemExpress | 100mg | EUR 153 |
Citraconic acid |
|||
HY-113298 | MedChemExpress | 5g | EUR 119 |
Hexacosanoic acid |
|||
HY-113301 | MedChemExpress | 10mg | EUR 119 |
Aminoadipic acid |
|||
HY-113328 | MedChemExpress | 1g | EUR 153 |
Nicotinuric acid |
|||
HY-113353 | MedChemExpress | 10mM/1mL | EUR 126 |
Petroselinic acid |
|||
HY-113362 | MedChemExpress | 10mM/1mL | EUR 113 |
Guanidinosuccinic acid |
|||
HY-113373 | MedChemExpress | 100mg | EUR 257 |
Imidazoleacetic acid |
|||
HY-113413 | MedChemExpress | 50mg | EUR 223 |
Obeticholic acid |
|||
HY-12222 | MedChemExpress | 100mg | EUR 383 |
Bempedoic acid |
|||
HY-12357 | MedChemExpress | 100mg | EUR 567 |
Eicosatetraynoic acid |
|||
HY-124108 | MedChemExpress | 1mg | EUR 160 |
Pentacosanoic acid |
|||
HY-124422 | MedChemExpress | 50mg | EUR 108 |
Glycodeoxycholic Acid |
|||
HY-125731 | MedChemExpress | 50mg | EUR 211 |
Phosphonoacetic acid |
|||
HY-128744 | MedChemExpress | 100mg | EUR 108 |
Oseltamivir (acid) |
|||
HY-13318 | MedChemExpress | 10mM/1mL | EUR 148 |
Fusidic acid |
|||
F019-100MG | TOKU-E | 100 mg | EUR 84 |
Fusidic acid |
|||
F019-1G | TOKU-E | 1 g | EUR 291 |
Hydrochloric acid |
|||
HC6025 | Bio Basic | 2.5L | EUR 97.85 |
Benzophenonetetracarboxylic acid |
|||
HY-100511 | MedChemExpress | 100mg | EUR 257 |
Benzenepentacarboxylic Acid |
|||
HY-100512 | MedChemExpress | 500mg | EUR 160 |
Kynurenic acid |
|||
HY-100806 | MedChemExpress | 10mM/1mL | EUR 113 |
Quinolinic acid |
|||
HY-100807 | MedChemExpress | 1g | EUR 119 |
Spaglumic Acid |
|||
HY-100921 | MedChemExpress | 50mg | EUR 187 |
Docosatrienoic Acid |
|||
HY-101408 | MedChemExpress | 10mg | EUR 173 |
Vanilpyruvic acid |
|||
HY-101416 | MedChemExpress | 10mg | EUR 147 |
Bucloxic acid |
|||
HY-101581 | MedChemExpress | 20mg | EUR 1703 |
Methylmalonic acid |
|||
HY-103395 | MedChemExpress | 500mg | EUR 108 |
Fuchsin acid |
|||
FB0469 | Bio Basic | 100g | EUR 98.72 |
Gallic acid |
|||
GB0476 | Bio Basic | 250g | EUR 71.75 |
Chlorogenic acid |
|||
HY-N0055 | MedChemExpress | 10mM/1mL | EUR 126 |
Ferulic acid |
|||
HY-N0060 | MedChemExpress | 500mg | EUR 165 |
Ginkgolic Acid |
|||
HY-N0077 | MedChemExpress | 10mg | EUR 402 |
Gambogic Acid |
|||
HY-N0087 | MedChemExpress | 5mg | EUR 133 |
Shikimic acid |
|||
HY-N0130 | MedChemExpress | 100mg | EUR 119 |
Ursolic acid |
|||
HY-N0140 | MedChemExpress | 10mM/1mL | EUR 156 |
Oleanolic Acid |
|||
HY-N0156 | MedChemExpress | 500mg | EUR 278 |
Orotic acid |
|||
HY-N0157 | MedChemExpress | 10mM/1mL | EUR 126 |
Hyodeoxycholic acid |
|||
HY-N0169 | MedChemExpress | 100mg | EUR 119 |
Caffeic acid |
|||
HY-N0172 | MedChemExpress | 5g | EUR 147 |
Glycyrrhizic acid |
|||
HY-N0184 | MedChemExpress | 100mg | EUR 147 |
Asiatic acid |
|||
HY-N0194 | MedChemExpress | 100mg | EUR 337 |
Nordihydroguaiaretic acid |
|||
HY-N0198 | MedChemExpress | 100mg | EUR 119 |
Benzoic acid |
|||
HY-N0216 | MedChemExpress | 100mg | EUR 108 |
Echinocystic acid |
|||
HY-N0271 | MedChemExpress | 10mM/1mL | EUR 172 |
Corosolic acid |
|||
HY-N0280 | MedChemExpress | 10mg | EUR 250 |
Protocatechuic acid |
|||
HY-N0294 | MedChemExpress | 1g | EUR 133 |
Caftaric acid |
|||
HY-N0321 | MedChemExpress | 10mM/1mL | EUR 414 |
Cholic acid |
|||
HY-N0324 | MedChemExpress | 10mM/1mL | EUR 126 |
Syringic acid |
|||
HY-N0339 | MedChemExpress | 100mg | EUR 108 |
Pachymic acid |
|||
HY-N0371 | MedChemExpress | 50mg | EUR 1262 |
Homovanillic acid |
|||
HY-N0384 | MedChemExpress | 100mg | EUR 119 |
Succinic acid |
|||
HY-N0420 | MedChemExpress | 10mM/1mL | EUR 151 |
Cichoric Acid |
|||
HY-N0457 | MedChemExpress | 10mg | EUR 133 |
Roburic acid |
|||
HY-N0481 | MedChemExpress | 1mg | EUR 113 |
Gallic acid |
|||
HY-N0523 | MedChemExpress | 500mg | EUR 147 |
Rosmarinic acid |
|||
HY-N0529 | MedChemExpress | 100mg | EUR 173 |
Deoxycholic acid |
|||
HY-N0593 | MedChemExpress | 10mM/1mL | EUR 126 |
Deacetylasperulosidic Acid |
|||
HY-N0594 | MedChemExpress | 10mg | EUR 436 |
Cinnamic acid |
|||
HY-N0610A | MedChemExpress | 10mM/1mL | EUR 113 |
Maslinic acid |
|||
HY-N0629 | MedChemExpress | 25mg | EUR 436 |
Carnosic acid |
|||
HY-N0644 | MedChemExpress | 50mg | EUR 223 |
(+)-Usnic acid |
|||
HY-N0656A | MedChemExpress | 100mg | EUR 108 |
Vanillic acid |
|||
HY-N0708 | MedChemExpress | 10mM/1mL | EUR 113 |
Neochlorogenic acid |
|||
HY-N0722 | MedChemExpress | 10mg | EUR 326 |
Linoleic acid |
|||
HY-N0729 | MedChemExpress | 10mM/1mL | EUR 113 |
Isoferulic acid |
|||
HY-N0761 | MedChemExpress | 10mM/1mL | EUR 113 |
Cryptochlorogenic acid |
|||
HY-N0787 | MedChemExpress | 10mM/1mL | EUR 126 |
Phytic acid |
|||
HY-N0814 | MedChemExpress | 250mg | EUR 108 |
Lithospermic acid |
|||
HY-N0823 | MedChemExpress | 5mg | EUR 142 |
Palmitic acid |
|||
HY-N0830 | MedChemExpress | 10mM/1mL | EUR 113 |
Quillaic acid |
|||
HY-N0839 | MedChemExpress | 5mg | EUR 533 |
Glycocholic acid |
|||
HY-N1423 | MedChemExpress | 10mM/1mL | EUR 113 |
Glycoursodeoxycholic acid |
|||
HY-N1424 | MedChemExpress | 10mg | EUR 119 |
Citric acid |
|||
HY-N1428 | MedChemExpress | 100mg | EUR 108 |
Oleic acid |
|||
HY-N1446 | MedChemExpress | 10mM/1mL | EUR 299 |
Betulonic acid |
|||
HY-N1451 | MedChemExpress | 10mM/1mL | EUR 126 |
Kaurenoic acid |
|||
HY-N1469 | MedChemExpress | 5mg | EUR 186 |
Polygalic acid |
|||
HY-N1479 | MedChemExpress | 20mg | EUR 257 |
Ursonic acid |
|||
HY-N1486 | MedChemExpress | 10mg | EUR 380 |
Oleanonic acid |
|||
HY-N1487 | MedChemExpress | 50mg | EUR 119 |
Gibberellic acid |
|||
HY-N1964 | MedChemExpress | 100mg | EUR 108 |
Artemisic acid |
|||
HY-N1984 | MedChemExpress | 10mM/1mL | EUR 113 |
Chebulagic acid |
|||
HY-N1996 | MedChemExpress | 25mg | EUR 1047 |
Veratric acid |
|||
HY-N2007 | MedChemExpress | 10mM/1mL | EUR 113 |
Anacardic Acid |
|||
HY-N2020 | MedChemExpress | 25mg | EUR 234 |
Taurochenodeoxycholic acid |
|||
HY-N2027 | MedChemExpress | 50mg | EUR 119 |